Tenoretic 100 and Crestor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tenoretic 100 (atenolol; chlorthalidone) and Crestor (rosuvastatin calcium). Common drug interactions include hypokalaemia among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Tenoretic 100 and Crestor. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Tenoretic 100?

Tenoretic 100 has active ingredients of atenolol; chlorthalidone. It is often used in high blood pressure. eHealthMe is studying from 935 Tenoretic 100 users. Check the latest studies of Tenoretic 100.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,761 Crestor users. Check the latest studies of Crestor.



On Jul, 16, 2026

20 people who take Tenoretic 100 and Crestor together, and have interactions are studied.

Tenoretic 100 and Crestor drug interactions.

What are the common drug interactions of Tenoretic 100 and Crestor, by gender? *:

female:

  1. Hypokalaemia (low potassium)
  2. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  3. Pain in extremity
  4. Drug ineffective
  5. Hepatic enzyme increased
  6. Hypersensitivity
  7. Nephritis interstitial (a kidney condition characterized by swelling in between the kidney tubules)
  8. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  9. Arthralgia (joint pain)
  10. Chest pain

male:

  1. Pain
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Gout (uric acid crystals building up in the body)
  4. High density lipoprotein decreased
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  6. Idiosyncratic drug reaction (unusual effect of the medication)
  7. Injury
  8. Multi-organ failure (multisystem organ failure)
  9. Pain in extremity
  10. Pancreatitis acute (sudden inflammation of pancreas)

What are the common drug interactions of Tenoretic 100 and Crestor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Carotid artery occlusion (artery blockage)
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Death
  6. Emotional distress
  7. Fear
  8. High density lipoprotein decreased
  9. Injury
  10. Multi-organ failure (multisystem organ failure)

60+:

  1. Hypokalaemia (low potassium)
  2. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  3. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  4. Dehydration (dryness resulting from the removal of water)
  5. Diabetic nephropathy (diabetic kidney disease)
  6. Drug hypersensitivity
  7. Essential hypertension (primary hypertension)
  8. Fatigue (feeling of tiredness)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Gout (uric acid crystals building up in the body)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 1 person, 5.00%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 5.00%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.00%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
  5. Depression: 1 person, 5.00%
  6. Autonomic Nervous System Imbalance (autonomic nervous system is of net equal emphasis): 1 person, 5.00%
  7. Arterial Occlusive Disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tenoretic 100 and Crestor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tenoretic 100 and Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tenoretic 100:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tenoretic 100 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Crestor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atenolol; chlorthalidone and rosuvastatin calcium (the active ingredients of Tenoretic 100 and Crestor, respectively), and Tenoretic 100 and Crestor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: